Subscribe
Close Sidebar
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Subscribe
Sign In
Our Views
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Magazine
Store
Study
PM Modi's Mann Ki Baat Programme Achieves New Milestone: 100 Crore Listeners Ahead Of 100th Episode
Swarajya Staff
8mo
Politics
Even Brief Exposure To Air Pollution May Impair Brain Function: Study
PTI
10mo
Health
Northern Bay Of Bengal Region India's Rainiest Part For The Last 10,200 Years, Finds New Study
Swarajya Staff
11mo
Science
New COVID-Like Virus Found In Bats Could Infect Humans, Resist Vaccines: Study
PTI
1yr
World
Two Antibodies Identified In Israel May Fight All Known COVID Strains: Study
PTI
1yr
Science
India Home To 18 Of 20 Cities With Most Severe Increase In PM2.5 Pollution: Study
PTI
1yr
Science
Arctic Is Warming Nearly Four Times Faster Than The Rest Of The World, Shows New Research
PTI
1yr
Science
Indian Scientists Develop Novel Strategy For Revitalising Obsolete Antibiotics To Counter Multi-Drug Resistant Bacteria
Swarajya Staff
1yr
Science
Newer Omicron Subvariants Escape Immunity Provided By Vaccination, Previous Infection: Study
PTI
1yr
Science
Indian Scientists Detect Neutral Electron Flow In Graphene; Research Likely To Shape Future Quantum Computation
Swarajya Staff
2yr
Science
'Fallacious And Completely Inaccurate': Govt On Media Reports Claiming COVID-19 Mortality In India Higher Than Official Counts
Swarajya Staff
2yr
Health
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Swarajya Staff
2yr
News Brief
Moderna COVID-19 Vaccine 76 Per Cent Effective Against Delta Variant, Pfizer 42 Per Cent: Study
IANS
2yr
News Brief
'Completely Misleading': Govt On Study Linking Ayurvedic Medicinal Herb Giloy To Liver Damage
Swarajya Staff
2yr
News Brief
Govt In Talks With J&J For Its Single-Dose COVID Vaccine, To Be Produced In India By Biological E: NITI Aayog's Dr Paul
Swarajya Staff
2yr
News Brief
Covaxin Has 93.4 Per Cent Efficacy Against Severe COVID-19 Cases, Overall Efficacy At 77.8 Per Cent: Bharat Biotech
Swarajya Staff
2yr
Insta
Exposure To Common Cold Virus Likely To Protect Against COVID-19 Infection, Finds Study
IANS
2yr
News Brief
DRDO Developed '2-DG' Drug Inhibits Coronavirus Multiplication, Likely To Work Against All COVID Variants: Study
IANS
2yr
News Brief
Serum Institute’s Covishield Vaccine Produces Antibodies Against B.1.617.1 Variant Of Coronavirus: ICMR Study
Swarajya Staff
3yr
Insta
AYUSH Ministry Sets Up High-Level Committee To Explore Potential Of Yoga As A Productivity Enhancing Tool
Swarajya Staff
3yr
News Brief
Monoclonal Antibody 'Cocktail' Effective Against Brazilian, UK Variants Of Coronavirus, Finds Study
IANS
3yr
Insta
Bharat Biotech's Covaxin Effective Against Coronavirus Variant Discovered In UK: ICMR Study
Swarajya Staff
3yr
Insta
Ayurveda Helped India Combat Malaria Thousands Of Years Ago, When All Others Failed: Hungarian Study
Swarajya Staff
3yr
Insta
Covid-19 Antibodies May Provide Immunity For At Least Five Months, Finds New Study
IANS
3yr
Insta
Union Minority Affairs Ministry Plans To Commission Study On Strengthening, Modernisation Of Madrasas
IANS
3yr
Insta
Covid-19 Not Characterised By Cytokine Storm, Specific Anti-Cytokine Therapies Unlikely To Benefit Critical Patients: Study
IANS
3yr
News Brief
Covid-19 Research Scandal: Medical Journal Lancet Retracts Study That Halted Trials Of Anti-Malarial Drug HCQ
IANS
4yr
News Brief
India’s Current Solar Tariffs Have Stabilised At Rates Lower Than Cost Of Existing Thermal Power, Finds Study
IANS
4yr
Insta
Scientists Identify 69 Drugs, Experimental Compounds That May Be Effective Against Coronavirus
Swarajya Staff
4yr
Insta
IIT-Hyderabad Develops Efficient Combination Therapy For Treatment Of Cancer With Minimal Side Effects
IANS
4yr
Insta
Load More
Get Swarajya in your inbox.
Subscribe
